Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial. [electronic resource]
Producer: 20000405Description: 74-9 p. digitalISSN:- 0959-8049
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Transitional Cell -- drug therapy
- Cisplatin -- administration & dosage
- Docetaxel
- Epirubicin -- administration & dosage
- Female
- Humans
- Male
- Middle Aged
- Paclitaxel -- administration & dosage
- Survival Analysis
- Taxoids
- Urinary Bladder Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.